Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy.
Q Yang, … , R Klevitsky, J Robbins
Q Yang, … , R Klevitsky, J Robbins
Published October 1, 1998
Citation Information: J Clin Invest. 1998;102(7):1292-1300. https://doi.org/10.1172/JCI3880.
View: Text | PDF
Research Article Article has an altmetric score of 4

A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy.

  • Text
  • PDF
Abstract

Familial hypertrophic cardiomyopathy can be caused by mutations in genes encoding sarcomeric proteins, including the cardiac isoform of myosin binding protein C (MyBP-C), and multiple mutations which cause truncated forms of the protein to be made are linked to the disease. We have created transgenic mice in which varying amounts of a mutated MyBP-C, lacking the myosin and titin binding domains, are expressed in the heart. The transgenically encoded, truncated protein is stable but is not incorporated efficiently into the sarcomere. The transgenic muscle fibers showed a leftward shift in the pCa2+-force curve and, importantly, their power output was reduced. Additionally, expression of the mutant protein leads to decreased levels of endogenous MyBP-C, resulting in a striking pattern of sarcomere disorganization and dysgenesis.

Authors

Q Yang, A Sanbe, H Osinska, T E Hewett, R Klevitsky, J Robbins

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1996 Total
Citations: 1 2 1 1 4 2 8 4 3 3 4 3 7 3 10 5 6 10 7 6 6 5 6 8 18 16 7 1 157
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (157)

Title and authors Publication Year
AAV9-mediated MYBPC3 gene therapy with optimized expression cassette enhances cardiac function and survival in MYBPC3 cardiomyopathy models
Greer-Short A, Greenwood A, Leon EC, Qureshi TN, von Kraut K, Wong J, Tsui JH, Reid CA, Cheng Z, Easter E, Yang J, Ho J, Steltzer S, Budan A, Cho M, Chandrakumar R, Cisne-Thompson O, Feathers C, Chung TW, Rodriguez N, Jones S, Alleyne-Levy C, Liu J, Jing F, Prince WS, Lin J, Ivey KN, Tingley WG, Hoey T, Lombardi LM
Nature Communications 2025
Hypertrophic cardiomyopathy in MYBPC3 carriers in aging
Ananthamohan K, Stelzer JE, Sadayappan S
2024
Molecular Pathways and Animal Models of Cardiomyopathies.
Orgil BO, Purevjav E
Advances in experimental medicine and biology 2024
Genome Editing and Pathological Cardiac Hypertrophy.
Kato T
Advances in experimental medicine and biology 2023
Targeting the sarcomere in inherited cardiomyopathies
Lehman SJ, Crocini C, Leinwand LA
Nature reviews. Cardiology 2022
Out of Control: The Role of the Ubiquitin Proteasome System in Skeletal Muscle during Inflammation
S Haberecht-Müller, E Krüger, J Fielitz
Biomolecules 2021
Breakdown of Filamentous Myofibrils by the UPS–Step by Step
D Aweida, S Cohen
Biomolecules 2021
Cardiomyocyte Dysfunction in Inherited Cardiomyopathies
R Hassoun, H Budde, A Mügge, N Hamdani
International journal of molecular sciences 2021
The N terminus of myosin-binding protein C extends toward actin filaments in intact cardiac muscle
S Rahmanseresht, KH Lee, TS OLeary, JW McNamara, S Sadayappan, J Robbins, DM Warshaw, R Craig, MJ Previs
The Journal of General Physiology 2021
Modelling genetic diseases for drug development: Hypertrophic cardiomyopathy
L Santini, C Palandri, C Nediani, E Cerbai, R Coppini
Pharmacological research : the official journal of the Italian Pharmacological Society 2020
Myocardial tissue-specific Dnmt1 knockout in rats protects against pathological injury induced by Adriamycin
TT Wu, YW Ma, X Zhang, W Dong, S Gao, JZ Wang, LF Zhang, D Lu
Laboratory Investigation 2020
Phenotypic variation and targeted therapy of hypertrophic cardiomyopathy using genetic animal models
MP Gannon, MS Link
Trends in Cardiovascular Medicine 2019
Advanced Evolution of Pathogenesis Concepts in Cardiomyopathies
CJ Li, CS Chen, GT Yiang, AP Tsai, WT Liao, MY Wu
Journal of Clinical Medicine 2019
Altered force generation and cell-to-cell contractile imbalance in hypertrophic cardiomyopathy
T Kraft, J Montag
Pflügers Archiv - European Journal of Physiology 2019
Functional significance of HCM mutants of tropomyosin, V95A and D175N, studied with in vitro motility assays
S Ishii, M Suzuki, S Ishiwata, M Kawai
2019
Impaired calcium handling and mitochondrial metabolic dysfunction as early markers of hypertrophic cardiomyopathy
HM Viola, LC Hool
Archives of Biochemistry and Biophysics 2019
Applying Patient-Specific Induced Pluripotent Stem Cells to Create a Model of Hypertrophic Cardiomyopathy
EV Dementyeva, SP Medvedev, VR Kovalenko, YV Vyatkin, EI Kretov, MM Slotvitsky, DN Shtokalo, EA Pokushalov, SM Zakian
Biochemistry (Moscow) 2019
Genetic Causes of Cardiac Disease
J Erdmann, A Moretti
2019
INDUCED PLURIPOTENT STEM CELLS FOR MODELLING ENERGETIC ALTERATIONS IN HYPERTROPHIC CARDIOMYOPATHY
Chrishan J A Ramachandra, K P Myu Mai Ja, Ying-Hsi Lin, Winston Shim, William A Boisvert, Derek J Hausenloy
Conditioning medicine 2019
Allelic imbalance and haploinsufficiency in MYBPC3-linked hypertrophic cardiomyopathy
AA Glazier, A Thompson, SM Day
Pflügers Archiv - European Journal of Physiology 2018
The genetics of hypertrophic cardiomyopathy
M Akhtar, P Elliott
Global Cardiology Science and Practice 2018
Recovery of left ventricular function following in vivo reexpression of cardiac myosin binding protein C
J Giles, JR Patel, A Miller, E Iverson, D Fitzsimons, RL Moss
The Journal of General Physiology 2018
Fibrosis in Disease: An Organ-Based Guide to Disease Pathophysiology and Therapeutic Considerations
MS Willis, CC Yates, JC Schisler
2018
Nueva mutación fundadora en MYBPC3: comparación fenotípica con la mutación de MYBPC3 más frecuente en España
M Sabater-Molina, D Saura, EG Sáez, J González-Carrillo, L Polo, I Pérez-Sánchez, MC Olmo, MJ Oliva-Sandoval, R Barriales-Villa, P Carbonell, D Pascual-Figal, JR Gimeno
Revista Española de Cardiología 2017
A Novel Founder Mutation in MYBPC3: Phenotypic Comparison With the Most Prevalent MYBPC3 Mutation in Spain
M Sabater-Molina, D Saura, EG Sáez, J González-Carrillo, L Polo, I Pérez-Sánchez, MC Olmo, MJ Oliva-Sandoval, R Barriales-Villa, P Carbonell, D Pascual-Figal, JR Gimeno
Revista Española de Cardiología (English Edition) 2017
The Genetic and Molecular Bases for Hypertrophic Cardiomyopathy: The Role for Calcium Sensitization
X Ren, N Hensley, MB Brady, WD Gao
Journal of Cardiothoracic and Vascular Anesthesia 2017
In vivo definition of cardiac myosin-binding protein C’s critical interactions with myosin
MS Bhuiyan, P McLendon, J James, H Osinska, J Gulick, B Bhandary, JN Lorenz, J Robbins
Pflügers Archiv - European Journal of Physiology 2016
Knockdown of fast skeletal myosin-binding protein C in zebrafish results in a severe skeletal myopathy
M Li, M Andersson-Lendahl, T Sejersen, A Arner
The Journal of General Physiology 2016
Congenital Heart Diseases: The Broken Heart
S Rickert-Sperling, RG Kelly, DJ Driscoll
2016
Animal and in silico models for the study of sarcomeric cardiomyopathies
DJ Duncker, J Bakkers, BJ Brundel, J Robbins, JC Tardiff, L Carrier
Cardiovascular Research 2015
Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease
AM Roberts, JS Ware, DS Herman, S Schafer, J Baksi, AG Bick, RJ Buchan, R Walsh, S John, S Wilkinson, F Mazzarotto, LE Felkin, S Gong, JA MacArthur, F Cunningham, J Flannick, SB Gabriel, DM Altshuler, PS Macdonald, M Heinig, AM Keogh, CS Hayward, NR Banner, DJ Pennell, DP O'Regan, TR San, A Marvao, TJ Dawes, A Gulati, EJ Birks, MH Yacoub, M Radke, M Gotthardt, JG Wilson, CJ O'Donnell, SK Prasad, PJ Barton, D Fatkin, N Hubner, JG Seidman, CE Seidman, SA Cook
Science Translational Medicine 2015
The genetic basis of hypertrophic cardiomyopathy in cats and humans
MD Kittleson, KM Meurs, SP Harris
Journal of Veterinary Cardiology 2015
Fluid mechanics of blood flow in human fetal left ventricles based on patient-specific 4D ultrasound scans
CQ Lai, GL Lim, M Jamil, CN Mattar, A Biswas, CH Yap
Biomechanics and Modeling in Mechanobiology 2015
Hypertrophic cardiomyopathy: how do mutations lead to disease?
JD Marsiglia, AC Pereira
Arquivos brasileiros de cardiologia 2014
Endothelin-1 Induces Myofibrillar Disarray and Contractile Vector Variability in Hypertrophic Cardiomyopathy-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
A Tanaka, S Yuasa, G Mearini, T Egashira, T Seki, M Kodaira, D Kusumoto, Y Kuroda, S Okata, T Suzuki, T Inohara, T Arimura, S Makino, K Kimura, A Kimura, T Furukawa, L Carrier, K Node, K Fukuda
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2014
Sarcomere Mutation-Specific Expression Patterns in Human Hypertrophic Cardiomyopathy
AS Helms, FM Davis, D Coleman, SN Bartolone, AA Glazier, F Pagani, JM Yob, S Sadayappan, E Pedersen, R Lyons, MV Westfall, R Jones, MW Russell, SM Day
Circulation. Cardiovascular genetics 2014
Cardiac myosin-binding protein C: hypertrophic cardiomyopathy mutations and structure–function relationships
V Sequeira, ER Witjas-Paalberends, DW Kuster, J van der Velden
Pflügers Archiv - European Journal of Physiology 2013
An Endogenously Produced Fragment of Cardiac Myosin-Binding Protein C Is Pathogenic and Can Lead to Heart Failure
A Razzaque, M Gupta, H Osinska, J Gulick, BC Blaxall, J Robbins
Circulation research 2013
Novel control of cardiac myofilament response to calcium by S-glutathionylation at specific sites of myosin binding protein C
BG Patel, T Wilder, RJ Solaro
Frontiers in physiology 2013
Functional dissection of myosin binding protein C phosphorylation
MK Gupta, J Gulick, J James, H Osinska, JN Lorenz, J Robbins
Journal of Molecular and Cellular Cardiology 2013
Emery and Rimoin's Principles and Practice of Medical Genetics
DC Wallace, MT Lott, V Procaccio
Emery and Rimoin's Principles and Practice of Medical Genetics 2013
MYBPC3's alternate ending: consequences and therapeutic implications of a highly prevalent 25 bp deletion mutation
DW Kuster, S Sadayappan
Pflügers Archiv - European Journal of Physiology 2013
Post-translational control of cardiac hemodynamics through myosin binding protein C
MK Gupta, J Robbins
Pflügers Archiv - European Journal of Physiology 2013
Myocardial ischemia, reperfusion, and infarction in chronically instrumented, intact, conscious, and unrestrained mice
HL Lujan, H Janbaih, HZ Feng, JP Jin, SE DiCarlo
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2012
Functional characterization of the human α-cardiac actin mutations Y166C and M305L involved in hypertrophic cardiomyopathy
M Müller, AJ Mazur, E Behrmann, RP Diensthuber, MB Radke, Z Qu, C Littwitz, S Raunser, CA Schoenenberger, DJ Manstein, HG Mannherz
Cellular and Molecular Life Sciences 2012
Cardiac myosin binding protein-C: redefining its structure and function
S Sadayappan, PP de Tombe
Biophysical Reviews 2012
Molecular mechanisms of sarcomere dysfunction in dilated and hypertrophic cardiomyopathy
AH Frazier, GA Ramirez-Correa, AM Murphy
Progress in Pediatric Cardiology 2011
Myosin binding protein C: implications for signal-transduction
R Knöll
Journal of Muscle Research and Cell Motility 2011
Signaling and Myosin-binding Protein C*
J James, J Robbins
The Journal of biological chemistry 2011
Biochemical and myofilament responses of the right ventricle to severe pulmonary hypertension
LA Walker, JS Walker, A Glazier, DR Brown, KR Stenmark, PM Buttrick
American journal of physiology. Heart and circulatory physiology 2011
Enhanced Active Cross-Bridges during Diastole: Molecular Pathogenesis of Tropomyosin's HCM Mutations
F Bai, A Weis, AK Takeda, PB Chase, M Kawai
Biophysical Journal 2011
Effects of nicotine administration in a mouse model of familial hypertrophic cardiomyopathy, α-tropomyosin D175N
RD Gaffin, SA Chowdhury, MS Alves, FA Dias, CT Ribeiro, RT Fogaca, DF Wieczorek, BM Wolska
American journal of physiology. Heart and circulatory physiology 2011
Signaling and Myosin-binding Protein C
J James, J Robbins
The Journal of biological chemistry 2011
Effects of nicotine administration in a mouse model of familial hypertrophic cardiomyopathy, α-tropomyosin D175N
RD Gaffin, SA Chowdhury, MS Alves, FA Dias, CT Ribeiro, RT Fogaca, DF Wieczorek, BM Wolska
American journal of physiology. Heart and circulatory physiology 2011
Biochemical and myofilament responses of the right ventricle to severe pulmonary hypertension
LA Walker, JS Walker, A Glazier, DR Brown, KR Stenmark, PM Buttrick
American journal of physiology. Heart and circulatory physiology 2011
In the Thick of It: HCM-Causing Mutations in Myosin Binding Proteins of the Thick Filament
SP Harris, RG Lyons, KL Bezold, J Robbins, C Seidman, H Watkins
Circulation research 2011
Narrative review: harnessing molecular genetics for the diagnosis and management of hypertrophic cardiomyopathy
L Wang, JG Seidman, CE Seidman
Annals of internal medicine 2010
Increased myofilament Ca2+-sensitivity and arrhythmia susceptibility
S Huke, BC Knollmann
Journal of Molecular and Cellular Cardiology 2010
Phosphorylation and function of cardiac myosin binding protein-C in health and disease
D Barefield, S Sadayappan
Journal of Molecular and Cellular Cardiology 2010
Screening mutations in myosin binding protein C3 gene in a cohort of patients with Hypertrophic Cardiomyopathy
MI Rodríguez-García, L Monserrat, M Ortiz, X Fernández, L Cazón, L Núñez, R Barriales-Villa, E Maneiro, E Veira, A Castro-Beiras, M Hermida-Prieto
BMC Medical Genetics 2010
Heart Failure in Clinical Practice
MY Henein
2010
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Expression Patterns of Cardiac Myofilament Proteins: Genomic and Protein Analysis of Surgical Myectomy Tissue From Patients With Obstructive Hypertrophic Cardiomyopathy
JL Theis, JM Bos, JD Theis, DV Miller, JA Dearani, HV Schaff, BJ Gersh, SR Ommen, RL Moss, MJ Ackerman
Circulation. Heart failure 2009
During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation
S Cohen, JJ Brault, SP Gygi, DJ Glass, DM Valenzuela, C Gartner, E Latres, AL Goldberg
The Journal of Cell Biology 2009
The ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathy
L Carrier, S Schlossarek, MS Willis, T Eschenhagen
Cardiovascular Research 2009
Hypertrophic Cardiomyopathy
JA Towbin
Pacing and Clinical Electrophysiology 2009
Molecular Pathology
WB Coleman, GJ Tsongalis
Molecular Pathology 2009
Appetite for destruction: E3 ubiquitin-ligase protection in cardiac disease
MS Willis, JC Schisler, C Patterson
Future Cardiology 2008
Build it up-Tear it down: protein quality control in the cardiac sarcomere
MS Willis, JC Schisler, AL Portbury, C Patterson
Cardiovascular Research 2008
Protein Science Encyclopedia
G Schmitz, T Langmann
Protein Science Encyclopedia 2008
Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis
F Cambronero, F Marin, V Roldan, D Hernandez-Romero, M Valdes, GY Lip
European Heart Journal 2008
Altered myocardial gene expression reveals possible maladaptive processes in heterozygous and homozygous cardiac myosin-binding protein C knockout mice
LM Eijssen, BJ Bosch, N Vignier, PJ Lindsey, CM Burg, L Carrier, PA Doevendans, GJ der Vusse, HJ Smeets
Genomics 2008
Cardiac myosin binding protein-C modulates actomyosin binding and kinetics in the in vitro motility assay
W Saber, KJ Begin, DM Warshaw, P VanBuren
Journal of Molecular and Cellular Cardiology 2008
The Death of Transcriptional Chauvinism in the Control and Regulation of Cardiac Contractility
S Sadayappan, J Robbins
Annals of the New York Academy of Sciences 2008
Crystal Structure of the C1 domain of Cardiac Myosin Binding Protein-C: Implications for Hypertrophic Cardiomyopathy
L Govada, L Carpenter, PC da Fonseca, JR Helliwell, P Rizkallah, E Flashman, NE Chayen, C Redwood, JM Squire
Journal of Molecular Biology 2008
Designing Heart Performance by Gene Transfer
J Davis, MV Westfall, D Townsend, M Blankinship, TJ Herron, G Guerrero-Serna, W Wang, E Devaney, JM Metzger
Physiological reviews 2008
Sourcebook of Models for Biomedical Research
PM Conn
2008
TGFbeta inducible early gene-1 (TIEG1) and cardiac hypertrophy: Discovery and characterization of a novel signaling pathway
NM Rajamannan, M Subramaniam, TP Abraham, VC Vasile, MJ Ackerman, DG Monroe, TL Chew, TC Spelsberg
Journal of Cellular Biochemistry 2007
Sarcomeric proteins and inherited cardiomyopathies
S Morimoto
Cardiovascular Research 2007
Genetic Basis of Hypertrophic Cardiomyopathy: From Bench to the Clinics
R Alcalai, JG Seidman, CE Seidman
Journal of Cardiovascular Electrophysiology 2007
Mouse models for cardiomyopathy research
F Sheikh, J Chen
Progress in Pediatric Cardiology 2007
Post-Genomic Cardiology
J Marín-García, MJ Goldenthal, GW Moe
Post-Genomic Cardiology 2007
Multiple Forms of Cardiac Myosin-binding Protein C Exist and Can Regulate Thick Filament Stability
I Kulikovskaya, GB McClellan, R Levine, S Winegrad
The Journal of General Physiology 2007
Cardiovascular Medicine
JT Willerson, HJ Wellens, JN Cohn, DR Holmes
2007
Molecular genetics in hypertrophic cardiomyopathy: towards individualized management of the disease
P Charron, M Komajda
Expert Review of Molecular Diagnostics 2006
The Genetic Bases of Cardiomyopathies
P Richard, E Villard, P Charron, R Isnard
Journal of the American College of Cardiology 2006
Cardiac myosin binding protein C phosphorylation is cardioprotective
S Sadayappan, H Osinska, R Klevitsky, JN Lorenz, M Sargent, JD Molkentin, CE Seidman, JG Seidman, J Robbins
Proceedings of the National Academy of Sciences 2006
GENES, CALCIUM AND MODIFYING FACTORS IN HYPERTROPHIC CARDIOMYOPATHY
T Tsoutsman, L Lam, C Semsarian
Clinical and Experimental Pharmacology and Physiology 2006
Models of cardiac fibrosis
NM Rajamannan
Drug Discovery Today: Disease Models 2006
Four and a Half LIM Protein 1 Binds Myosin-binding Protein C and Regulates Myosin Filament Formation and Sarcomere Assembly
MJ McGrath, DL Cottle, MA Nguyen, JM Dyson, ID Coghill, PA Robinson, M Holdsworth, BS Cowling, EC Hardeman, CA Mitchell, S Brown
The Journal of biological chemistry 2006
Sarcomeric Proteins and Familial Hypertrophic Cardiomyopathy: Linking Mutations in Structural Proteins to Complex Cardiovascular Phenotypes
JC Tardiff
Heart Failure Reviews 2005
Disruption of myofibrillar proteins in cardiac muscle of Calomys callosus chronically infected with Trypanosoma cruzi and treated with immunosuppressive agent
NN Taniwaki, WK Andreoli, KS Calabrese, S Silva, RA Mortara
Parasitology Research 2005
Cardiac Myosin-Binding Protein-C Phosphorylation and Cardiac Function
S Sadayappan, J Gulick, H Osinska, LA Martin, HS Hahn, GW Dorn, R Klevitsky, CE Seidman, JG Seidman, J Robbins
Circulation research 2005
Principles of Molecular Cardiology
MS Runge, C Patterson
2005
Sliding Filament Mechanism in Muscle Contraction
H Sugi
2005
Disruption of myofibrillar proteins in cardiac muscle of Calomys callosus chronically infected with Trypanosoma cruzi and treated with immunosuppressive agent
NN Taniwaki, WK Andreoli, KS Calabrese, S da Silva, RA Mortara
Parasitology Research 2005
alpha-Tropomyosin mutations Asp(175)Asn and Glu(180)Gly affect cardiac function in transgenic rats in different ways
D Wernicke, C Thiel, CM Duja-Isac, KV Essin, M Spindler, DJ Nunez, R Plehm, N Wessel, A Hammes, RJ Edwards, A Lippoldt, U Zacharias, H Strömer, S Neubauer, MJ Davies, I Morano, L Thierfelder
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2004
Myosin binding protein C: Structural abnormalities in familial hypertrophic cardiomyopathy
CE OAKLEY, BD HAMBLY, PM CURMI, LJ BROWN
Cell Research 2004
Hypertrophic Cardiomyopathy: From “Heart Tumour” to a Complex Molecular Genetic Disorder
A Doolan, L Nguyen, C Semsarian
Heart, Lung and Circulation 2004
Reduced cross-bridge dependent stiffness of skinned myocardium from mice lacking cardiac myosin binding protein-C
BM Palmer, BK McConnell, GH Li, CE Seidman, JG Seidman, TC Irving, NR Alpert, DW Maughan
Molecular and Cellular Biochemistry 2004
The Physiological Genomics of the Critically Ill Mouse
C Ince
2004
Hypertrophic cardiomyopathy: from gene defect to clinical disease
MW CHUNG, T TSOUTSMAN, C SEMSARIAN
Cell Research 2003
Hypertrophic cardiomyopathy: two homozygous cases with “typical” hypertrophic cardiomyopathy and three new mutations in cases with progression to dilated cardiomyopathy
L Nanni, M Pieroni, C Chimenti, B Simionati, R Zimbello, A Maseri, A Frustaci, G Lanfranchi
Biochemical and Biophysical Research Communications 2003
Troponin I in the murine myocardium: influence on length-dependent activation and interfilament spacing
JP Konhilas, TC Irving, BM Wolska, EE Jweied, AF Martin, RJ Solaro, PP de Tombe
The Journal of Physiology 2003
Effect of MyBP-C Binding to Actin on Contractility in Heart Muscle
I Kulikovskaya, G McClellan, J Flavigny, L Carrier, S Winegrad
The Journal of General Physiology 2003
Effect of extraction of myosin binding protein C on contractility of rat heart
I Kulikovskaya, G McClellan, R Levine, S Winegrad
American journal of physiology. Heart and circulatory physiology 2003
A Novel Variant of Cardiac Myosin-binding Protein-C That Is Unable to Assemble into Sarcomeres Is Expressed in the Aged Mouse Atrium
N Sato, T Kawakami, A Nakayama, H Suzuki, H Kasahara, T Obinata
Molecular biology of the cell 2003
Molecular diagnosis of myocardial disease
JA Towbin, NE Bowles
Expert Review of Molecular Diagnostics 2002
Calcineurin and hypertrophic heart disease: novel insights and remaining questions
OF Bueno, E Rooij, JD Molkentin, PA Doevendans, LJ de Windt
Cardiovascular Research 2002
Genética molecular de las miocardiopatías
R Roberts
Revista Española de Cardiología 2002
Transgenic Rabbits Expressing Mutant Essential Light Chain do not Develop Hypertrophic Cardiomyopathy
J James, Y Zhang, K Wright, S Witt, E Glascock, H Osinska, R Klevitsky, L Martin, K Yager, A Sanbe, J Robbins
Journal of Molecular and Cellular Cardiology 2002
Molecular Mechanisms of Inherited Cardiomyopathies
D Fatkin, RM Graham
Physiological reviews 2002
Hypertrophic Cardiomyopathy in Cardiac Myosin Binding Protein-C Knockout Mice
SP Harris, CR Bartley, TA Hacker, KS McDonald, PS Douglas, ML Greaser, PA Powers, RL Moss
Circulation research 2002
Structure-Function Relationships in Myosin Binding Protein-C: Taking Off the Blinders and Collaring Hypertrophic Cardiomyopathy
J Robbins, DW Benson
Circulation research 2002
Myofibrillogenesis
DK Dube
2002
Novel cardiac troponin T mutation as a cause of familial dilated cardiomyopathy
D Li, GZ Czernuszewicz, O Gonzalez, T Tapscott, A Karibe, JB Durand, R Brugada, R Hill, JM Gregoritch, JL Anderson, M Quiñones, LL Bachinski, R Roberts
Circulation 2001
Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy
J Erdmann, J Raible, J Maki-Abadi, J Hammann, B Wollnik, E Frantz, E Fleck, V Regitz-Zagrosek, M Hummel, R Hetzer
Journal of the American College of Cardiology 2001
Cardiac hypertrophy and failure: lessons learned from genetically engineered mice
Y Takeishi, RA Walsh
Acta Physiologica Scandinavica 2001
COOH-terminal truncated human cardiac MyBP-C alters myosin filament organization
P Sébillon, G Bonne, J Flavigny, S Venin, A Rouche, M Fiszman, K Vikstrom, L Leinwand, L Carrier, K Schwartz
Comptes Rendus de l'Académie des Sciences - Series III - Sciences de la Vie 2001
The molecular genetic basis for hypertrophic cardiomyopathy
AJ Marian, R Roberts
Journal of Molecular and Cellular Cardiology 2001
Molecular genetics and pathogenesis of hypertrophic cardiomyopathy
AJ Marian, L Salek, S Lutucuta
Minerva medica 2001
The Genetic Basis for Cardiomyopathy
JG Seidman, C Seidman
Cell 2001
Heart Physiology and Pathophysiology
NS Dhalla, RM Temsah, T Netticadan, MS Sandhu
Heart Physiology and Pathophysiology 2001
Modelos animales genéticamente modificados en investigación cardiovascular
F Dalloz, H Osinska, J Robbins
Revista Española de Cardiología 2001
Manipulating the Contractile Apparatus: Genetically Defined Animal Models of Cardiovascular Disease
F Dalloz, H Osinska, J Robbins
Journal of Molecular and Cellular Cardiology 2001
Phenotypic Deficits in Mice Expressing a Myosin Binding Protein C Lacking the Titin and Myosin Binding Domains
Q Yang, H Osinska, R Klevitsky, J Robbins
Journal of Molecular and Cellular Cardiology 2001
Gene Mutation in Cardiac Myosin Binding Protein C
S Winegrad
Journal of Molecular and Cellular Cardiology 2001
Examining the in Vivo Role of the Amino Terminus of the Essential Myosin Light Chain
A Sanbe, J Gulick, J Fewell, J Robbins
The Journal of biological chemistry 2001
Gender and aging in a transgenic mouse model of hypertrophic cardiomyopathy
MC Olsson, BM Palmer, LA Leinwand, RL Moore
American journal of physiology. Heart and circulatory physiology 2001
Cardiovascular Genetics for Clinicians
PA Doevendans, AA Wilde
2001
Cardiovascular Physiology in the Genetically Engineered Mouse
BD Hoit, RA Walsh
2001
Formation of the Heart and Its Regulation
RJ Tomanek, RB Runyan
2001
Comparison of Two Murine Models of Familial Hypertrophic Cardiomyopathy
BK McConnell, D Fatkin, C Semsarian, KA Jones, D Georgakopoulos, CT Maguire, MJ Healey, JO Mudd, IP Moskowitz, DA Conner, M Giewat, H Wakimoto, CI Berul, FJ Schoen, DA Kass, CE Seidman, JG Seidman
Circulation research 2001
Meeting Koch’s postulates for calcium signaling in cardiac hypertrophy
KR Chien
Journal of Clinical Investigation 2000
FROM THESARCOMERE TO THENUCLEUS: Role of Genetics and Signaling in Structural Heart Disease
RL Nicol, N Frey, EN Olson
Annual Review of Genomics and Human Genetics 2000
Cardiac Electrophysiology in Genetically Engineered Mice
J Gehrmann, CI Berul
Journal of Cardiovascular Electrophysiology 2000
Animal models of hypertrophic cardiomyopathy
A Maass, LA Leinwand
Current Opinion in Cardiology 2000
Remodeling the Cardiac Sarcomere Using Transgenesis
J Robbins
Annual Review of Physiology 2000
A role for C-protein in the regulation of contraction and intracellular Ca2+ in intact rat ventricular myocytes
SC Calaghan, J Trinick, PJ Knight, E White
The Journal of Physiology 2000
To the heart of myofibril assembly
CC Gregorio, PB Antin
Trends in Cell Biology 2000
Regional dysfunction correlates with myofiber disarray in transgenic mice with ventricular expression of ras
WJ Karlon, AD McCulloch, JW Covell, JJ Hunter, JH Omens
American journal of physiology. Heart and circulatory physiology 2000
Myosin light chain replacement in the heart
A Sanbe, J Gulick, E Hayes, D Warshaw, H Osinska, CB Chan, R Klevitsky, J Robbins
American journal of physiology. Heart and circulatory physiology 2000
Myosin Binding Protein C, a Phosphorylation-Dependent Force Regulator in Muscle That Controls the Attachment of Myosin Heads by Its Interaction With Myosin S2
G Kunst, KR Kress, M Gruen, D Uttenweiler, M Gautel, RH Fink
Circulation research 2000
Myosin Binding Protein C, a Potential Regulator of Cardiac Contractility
S Winegrad
Circulation research 2000
A Newly Created Splice Donor Site in Exon 25 of the MyBP-C Gene Is Responsible for Inherited Hypertrophic Cardiomyopathy With Incomplete Disease Penetrance
JA Moolman, S Reith, K Uhl, S Bailey, M Gautel, B Jeschke, C Fischer, J Ochs, WJ McKenna, H Klues, HP Vosberg
Circulation 2000
Genetic Manipulation of the Rabbit Heart via Transgenesis
J James, A Sanbe, K Yager, L Martin, R Klevitsky, J Robbins
Circulation 2000
Elastic Filaments of the Cell
HL Granzier, GH Pollack
2000
Molecular genetics of card iomyopathies*1
G Shah
Journal of Nuclear Cardiology 2000
Molecular genetics of hypertrophic cardiomyopathy.
Towbin JA
Current Cardiology Reports 2000
Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice
BK McConnell, KA Jones, D Fatkin, LH Arroyo, RT Lee, O Aristizabal, DH Turnbull, D Georgakopoulos, D Kass, M Bond, H Niimura, FJ Schoen, D Conner, DA Fischman, CE Seidman, JG Seidman, DH Fischman
Journal of Clinical Investigation 1999
A transgenic rabbit model for human hypertrophic cardiomyopathy
AJ Marian, Y Wu, DS Lim, M McCluggage, K Youker, QT Yu, R Brugada, F DeMayo, M Quinones, R Roberts
Journal of Clinical Investigation 1999
Animal models of familial hypertrophic cardiomyopathy
H Farza, H Watkins
Molecular Medicine Today 1999
Variability in the ratio of mutant to wildtype myosin heavy chain present in the soleus muscle of patients with familial hypertrophic cardiomyopathy. A new approach for the quantification of mutant to wildtype protein
V Nier, I Schultz, B Brenner, WG Forssmann, M Raida
FEBS Letters 1999
COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and/or incorporation in fetal rat cardiomyocytes
J Flavigny, M Souchet, P Sébillon, I Berrebi-Bertrand, B Hainque, A Mallet, A Bril, K Schwartz, L Carrier
Journal of Molecular Biology 1999
Functional consequences of troponin T mutations found in hypertrophic cardiomyopathy
LS Tobacman, D Lin, C Butters, C Landis, N Back, D Pavlov, E Homsher
The Journal of biological chemistry 1999
Cardiac Myosin Binding Protein C
S Winegrad
Circulation research 1999
Molecular genetics of hypertrophic cardiomyopathy
R Roberts, AJ Marian, L Bachinski
Journal of Cardiac Failure 1996

← Previous 1 2 3 … 6 7 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 1 X users
Referenced in 4 patents
98 readers on Mendeley
1 readers on CiteULike
See more details